Tespa1 is involved in late thymocyte development through the regulation of TCR-mediated signaling-Reference-Cited by-同舟云学术

Tespa1 is involved in late thymocyte development through the regulation of TCR-mediated signaling

Published:2012-05-06 Issue:6 Volume:13 Page:560-568
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Wang Di,Zheng Mingzhu,Lei Lei,Ji Jian,Yao Yunliang,Qiu Yuanjun,Ma Lie,Lou Jun,Ouyang Chuan,Zhang Xue,He Yuewei,Chi Jun,Wang Lie,Kuang Ying,Wang Jianli,Cao Xuetao,Lu Linrong

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.2301.pdf

Reference34 articles.

1. Starr, T.K., Jameson, S.C. & Hogquist, K.A. Positive and negative selection of T cells. Annu. Rev. Immunol. 21, 139–176 (2003).

2. Germain, R.N. T-cell development and the CD4–CD8 lineage decision. Nat. Rev. Immunol. 2, 309–322 (2002).

3. Bosselut, R. CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nat. Rev. Immunol. 4, 529–540 (2004).

4. Singer, A., Adoro, S. & Park, J.H. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 8, 788–801 (2008).

5. Werlen, G. & Palmer, E. The T-cell receptor signalosome: a dynamic structure with expanding complexity. Curr. Opin. Immunol. 14, 299–305 (2002).

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GRP75-dependent mitochondria-ER contacts ensure cell survival during early mouse thymocyte development;Developmental Cell;2024-07

2. Mitochondrial dynamics and metabolic regulation control T cell fate in the thymus;Frontiers in Immunology;2024-01-15

3. TCR Affinity and Signaling During Thymocyte Selection;Reference Module in Life Sciences;2024

4. Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer;Nature Communications;2023-11-27

5. Tespa1 deficiency reduces the antitumour immune response by decreasing CD8+T cell activity in a mouse Lewis lung cancer model;International Immunopharmacology;2023-11